Short-acting GLP-1 receptor agonists include exenatide (Byetta, with limited US availability) and lixisenatide (Adlyxin, discontinued in the US market)
Recommendations are made independently based on research, publicly available information, and editorial judgment
This material is intended for controlled research environments where compound identity, molecular structure, solubility, stability, and analytical profile may be evaluated using appropriate laboratory methods
It's perfect for addressing wrinkles, loss of elasticity, sun damage, and uneven tone
However, this nomenclature is inaccurate, since humans and other higher organisms are capable of synthesizing L-carnitine endogenously